Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Finasteride treats hair loss but may affect prostate cancer detection.

A new compound was effective for imaging prostate cancer in rats.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Finasteride reduces bleeding during prostate surgery.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Female hair loss patients more likely to have dry eye and gland issues.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

Kolaviron and quercetin may help treat prostate issues.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The normal human prostate does not significantly affect blood DHT levels.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Dutasteride may help shrink prostate cancer tumors.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.